128 related articles for article (PubMed ID: 29071791)
1. Current Status of Hepatitis C Virus-Infected Maintenance Hemodialysis Patients in Japan.
Abe T; Oomori S; Obara W
Ther Apher Dial; 2018 Feb; 22(1):58-60. PubMed ID: 29071791
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus infection in maintenance hemodialysis patients: recommendations for diagnostics and treatment.
Dzekova-Vidimliski P; Sikole A
Int J Artif Organs; 2017 Feb; 39(12):590-595. PubMed ID: 28165585
[TBL] [Abstract][Full Text] [Related]
3. [The management of dialysis patients seropositive for HBsAg, anti-HCV, or anti-HIV antibodies].
Fabrizi F; Messa P
G Ital Nefrol; 2012; 29 Suppl 56():S78-84. PubMed ID: 23059944
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of hepatitis C virus infection and genotypes in patient with chronic kidney disease undergoing hemodialysis.
de Jesus Rodrigues de Freitas M; Fecury AA; de Almeida MK; Freitas AS; de Souza Guimarães V; da Silva AM; da Costa YF; da Costa RA; Ferreira P; Martins LC
J Med Virol; 2013 Oct; 85(10):1741-5. PubMed ID: 23852735
[TBL] [Abstract][Full Text] [Related]
5. Current elimination status of hepatitis C virus-infected maintenance hemodialysis patients in Iwate Prefecture, Japan.
Miyasaka A; Yoshida Y; Suzuki A; Endo K; Kakisaka K; Oikawa T; Abe T; Obara W; Matsumoto T
Ther Apher Dial; 2023 Oct; 27(5):848-854. PubMed ID: 37125473
[TBL] [Abstract][Full Text] [Related]
6. Multicenter study of pegylated interferon α-2a monotherapy for hepatitis C virus-infected patients on hemodialysis: REACH study.
Kikuchi K; Akiba T; Nitta K; Masakane I; Ando R; Izumi N; Atsukawa M; Yamazaki C; Kato F; Hotta N; Tominaga Y; Orito E; Hora K; Nagasawa M; Kasahara H; Kawaguchi M; Kimura H; Ikebe N; Kawanishi H; Moriishi M; Shigemoto K; Harada T; Hirakata H; Watanabe H; Nosaki T; Tsubouchi H; Imawari M; Akizawa T
Ther Apher Dial; 2014 Dec; 18(6):603-11. PubMed ID: 25196061
[TBL] [Abstract][Full Text] [Related]
7. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).
Minutolo R; Aghemo A; Chirianni A; Fabrizi F; Gesualdo L; Giannini EG; Maggi P; Montinaro V; Paoletti E; Persico M; Perticone F; Petta S; Puoti M; Raimondo G; Rendina M; Zignego AL;
Dig Liver Dis; 2018 Nov; 50(11):1133-1152. PubMed ID: 30266305
[TBL] [Abstract][Full Text] [Related]
8. [Sofosbuvir and daclatasvir combination therapy in hemodialysis patient with liver transplantation].
Hachicha M; Botta-Fridlund D
Nephrol Ther; 2016 Dec; 12(7):536-538. PubMed ID: 27825643
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis.
Toyoda H; Kumada T; Tada T; Takaguchi K; Ishikawa T; Tsuji K; Zeniya M; Iio E; Tanaka Y
J Gastroenterol; 2016 Jul; 51(7):741-7. PubMed ID: 26872889
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus infection in dialysis patients.
Sułowicz W; Radziszewski A; Chowaniec E
Hemodial Int; 2007 Jul; 11(3):286-95. PubMed ID: 17576291
[TBL] [Abstract][Full Text] [Related]
11. Antiviral treatment and prognosis in patients undergoing maintenance hemodialysis due to hepatitis C virus.
Zhang W; Yuan Q; Ning J; Li X; Wu A; Xiao X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1332-1337. PubMed ID: 35232901
[TBL] [Abstract][Full Text] [Related]
12. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).
Minutolo R; Aghemo A; Chirianni A; Fabrizi F; Gesualdo L; Giannini EG; Maggi P; Montinaro V; Paoletti E; Persico M; Perticone F; Petta S; Puoti M; Raimondo G; Rendina M; Zignego AL; ; ; ;
Intern Emerg Med; 2018 Dec; 13(8):1139-1166. PubMed ID: 30255464
[TBL] [Abstract][Full Text] [Related]
13. Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients.
Vidales-Braz BM; da Silva NM; Lobato R; Germano FN; da Mota LD; Barros EJ; de Martinez AM
Virol J; 2015 Feb; 12():8. PubMed ID: 25644891
[TBL] [Abstract][Full Text] [Related]
14. Chronic hepatitis C and chronic kidney disease: Advances, limitations and unchartered territories.
Mendizabal M; Reddy KR
J Viral Hepat; 2017 Jun; 24(6):442-453. PubMed ID: 28107583
[TBL] [Abstract][Full Text] [Related]
15. [HCV RNA clearance after treatment with interferon-alpha in chronic hemodialysis patients with or without coinfection by HGV/HGBV-C].
Rostaing L; Izopet J; Moussion F; Alric L; Verdier D; That HT; Duffaut M; Durand D; Puel J; Suc JM
Nephrologie; 1997; 18(7):281-6. PubMed ID: 9496568
[TBL] [Abstract][Full Text] [Related]
16. Should all dialysis patients with hepatitis C be treated? If so, before or after kidney transplantation?
Jadoul M; Martin P
Semin Dial; 2017 Sep; 30(5):395-397. PubMed ID: 28786139
[TBL] [Abstract][Full Text] [Related]
17. Effect and Safety of Daclatasvir-Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b -Infected Patients on Hemodialysis.
Miyazaki R; Miyagi K
Ther Apher Dial; 2016 Oct; 20(5):462-467. PubMed ID: 27098678
[TBL] [Abstract][Full Text] [Related]
18. [Hepatitis C virus and chronic progressive kidney disease].
Kes P; Slavicek J
Acta Med Croatica; 2009 Dec; 63(5):431-6. PubMed ID: 20198903
[TBL] [Abstract][Full Text] [Related]
19. Elimination of Hepatitis C Virus in a Dialysis Population: A Collaborative Care Model in Taiwan.
Hu TH; Su WW; Yang CC; Yang CC; Kuo WH; Chen YY; Yeh YH; Chen SS; Tsao YY; Chen KM; Yan SL; Lai JH; Yao CD; Lim CH; Jen HH; Yeh YP; Chen SL; Chen HH; Chen SC;
Am J Kidney Dis; 2021 Oct; 78(4):511-519.e1. PubMed ID: 33940114
[TBL] [Abstract][Full Text] [Related]
20. [Viral hepatitis C in patients with terminal chronic renal insufficiency. III. Viral quantification].
González-Michaca L; Soto-Ramírez LE; Rodríguez R; Gamba G
Rev Invest Clin; 2001; 53(1):21-7. PubMed ID: 11332047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
